XML 50 R21.htm IDEA: XBRL DOCUMENT
v3.21.2

Share Capital and Other Equity Instruments (Tables) | 3 Months Ended | 12 Months Ended
--- | --- | ---
Mar. 31, 2021 | Dec. 31, 2020
Schedule of Stock Options |
|  | Number of Shares |  |  | Weighted Average Exercise Price (USD) |  |  | Weighted Average Grant Date Fair Value (USD) |  |  | Weighted Average Remaining Contractual Term (years) |  |  | Aggregate Intrinsic Value (USD) |
Outstanding – January 1, 2021 |  |  | 929,765 |  |  | $ | 1.53 |  |  | $ | 2.50 |  |  |  |  |  |  |  |  |
Expired forfeited, or cancelled |  |  | (560,404 | ) |  | $ | 1.65 |  |  | $ | 1.66 |  |  |  |  |  |  |  |  |
Outstanding – December 31, 2020 |  |  | 369,361 |  |  | $ | 1.35 |  |  | $ | 3.80 |  |  |  | 5.2 |  |  | $ | 636,156 |
Exercisable at December 31, 2020 |  |  | 369,361 |  |  | $ | 1.35 |  |  | $ | 3.80 |  |  |  | 5.2 |  |  | $ | 636,156 |
|  | Number of Shares |  |  | Weighted Average Exercise Price (USD) |  |  | Weighted Average Grant Date Fair Value (USD) |  |  | Weighted Average Remaining Contractual Term (years) |  |  | Aggregate Intrinsic Value (USD) |
Outstanding – January 1, 2019 |  |  | 689,832 |  |  | $ | 1.94 |  |  | $ | 1.94 |  |  |  |  |  |  |  |  |
Granted |  |  | 448,713 |  |  | $ | 1.99 |  |  | $ | 1.49 |  |  |  |  |  |  |  |  |
Expired, forfeited, or cancelled |  |  | (341,172 | ) |  | $ | 1.99 |  |  | $ | 0.36 |  |  |  |  |  |  |  |  |
Outstanding – December 31, 2019 |  |  | 797,373 |  |  | $ | 1.99 |  |  | $ | 0.72 |  |  |  |  |  |  |  |  |
Granted |  |  | 378,800 |  |  | $ | 0.94 |  |  | $ | 5.22 |  |  |  |  |  |  |  |  |
Expired forfeited, or cancelled |  |  | (246,408 | ) |  | $ | 1.94 |  |  | $ | 0.88 |  |  |  |  |  |  |  |  |
Outstanding – December 31, 2020 |  |  | 929,765 |  |  | $ | 1.53 |  |  | $ | 2.50 |  |  |  | 6.1 |  |  | $ | 2,537,245 |
Exercisable at December 31, 2020 |  |  | 929,765 |  |  | $ | 1.53 |  |  | $ | 2.50 |  |  |  | 6.1 |  |  | $ | 2,537,245 |
Schedule of Fair Value Assumption of Stock Option |  | The Company utilized the Black-Scholes option-pricing model to determine the fair value of these stock options, using the assumptions as outlined below.
Stock Price |  | $ | 5.92 |
Dividend Yield |  |  | 0 | %
Expected Volatility |  |  | 84.7 | %
Weighted Average Risk-Free Interest Rate |  |  | 0.37 | %
Expected life (in years) |  |  | 1.5 – 4.2 |
Schedule of Warrants | The following table summarizes information about shares issuable under warrants outstanding at March 31, 2021:
|  | Warrant shares outstanding |  |  | Weighted average exercise price (USD) |  |  | Weighted average remaining life |  |  | Intrinsic value |
Outstanding at January 1, 2021 |  |  | 3,661,178 |  |  | $ | 1.98 |  |  |  |  |  |  |  |  |
Issued |  |  | 3,535,519 |  |  | $ | 4.93 |  |  |  |  |  |  |  |  |
Exercised |  |  | (851,099 | ) |  | $ | 4.17 |  |  |  |  |  |  |  |  |
Outstanding at March 31, 2021 |  |  | 6,345,598 |  |  | $ | 3.33 |  |  |  | 4.9 |  |  | $ | 6,049,152 |
Exercisable at March 31, 2021 |  |  | 6,345,598 |  |  | $ | 3.33 |  |  |  | 4.9 |  |  | $ | 6,049,152 |
| The following table summarizes information about shares issuable under warrants outstanding at December 31, 2020:
|  | Warrant shares outstanding |  |  | Weighted average exercise price (USD) |  |  | Weighted average remaining life |  |  | Intrinsic value |
Outstanding at January 1, 2019 |  |  | 219,510 |  |  | $ | 2.95 |  |  |  | 0.08 |  |  |  |  |
Issued |  |  | 84,381 |  |  | $ | 3.21 |  |  |  |  |  |  |  |  |
Outstanding at December 31, 2019 |  |  | 303,891 |  |  | $ | 3.02 |  |  |  | 1.06 |  |  | $ | - |
Issued |  |  | 3,222,331 |  |  | $ | 1.96 |  |  |  |  |  |  |  |  |
Forfeited |  |  | (274,816 | ) |  | $ | (3.00 | ) |  |  |  |  |  |  |  |
Outstanding at December 31, 2020 |  |  | 3,251,406 |  |  | $ | 1.95 |  |  |  | 4.97 |  |  | $ | - |
Exercisable at December 31, 2020 |  |  | 3,251,406 |  |  | $ | 1.95 |  |  |  | 4.97 |  |  | $ | 8,040,545 |
Restricted Stock Awards [Member] |  |
Schedule of Restricted Stock Units and Awards Activity | The Company’s activity in restricted common stock was as follows for the three months ended March 31, 2021:
|  | Number of shares |  |  | Weighted average grant date fair value |
Non–vested at January 1, 2021 |  |  | - |  |  | $ | - |
Granted |  |  | 70,986 |  |  | $ | 4.16 |
Vested |  |  | (44,390 | ) |  | $ | 4.49 |
Non–vested at March 31, 2021 |  |  | 26,596 |  |  | $ | 3.61 |
Restricted Stock Units [Member] |  |
Schedule of Restricted Stock Units and Awards Activity | The Company’s activity in restricted stock units was as follows for the three months ended March 31, 2021:
|  | Number of shares |  |  | Weighted average grant date fair value |
Non–vested at January 1, 2021 |  |  | - |  |  | $ | - |
Granted |  |  | 3,279,284 |  |  | $ | 4.41 |
Vested |  |  | (1,207,825 | ) |  | $ | 4.46 |
Non–vested at March 31, 2021 |  |  | 2,071,459 |  |  | $ | 4.38 |

X
- Definition Tabular disclosure of input and valuation technique used to measure fair value and change in valuation approach and technique used to measure similar asset in prior period by class of asset or liability on non-recurring basis. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 820 -SubTopic 10 -Section 50 -Paragraph 2 -Subparagraph (bbb) -URI http://asc.fasb.org/extlink&oid=123874694&loc=d3e19207-110258 + Details
Name: | us-gaap_FairValueAssetsMeasuredOnNonrecurringBasisValuationTechniquesTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of the number and weighted-average grant date fair value for restricted stock units that were outstanding at the beginning and end of the year, and the number of restricted stock units that were granted, vested, or forfeited during the year. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 718 -SubTopic 10 -Section 50 -Paragraph 2 -Subparagraph (c)(1) -URI http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901 + Details
Name: | us-gaap_ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure for stock option plans. Includes, but is not limited to, outstanding awards at beginning and end of year, grants, exercises, forfeitures, and weighted-average grant date fair value. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 718 -SubTopic 10 -Section 50 -Paragraph 2 -Subparagraph (d) -URI http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901 Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 718 -SubTopic 10 -Section 50 -Paragraph 2 -Subparagraph (e) -URI http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901 Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 718 -SubTopic 10 -Section 50 -Paragraph 2 -Subparagraph (c)(1) -URI http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901 + Details
Name: | us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of warrants or rights issued. Warrants and rights outstanding are derivative securities that give the holder the right to purchase securities (usually equity) from the issuer at a specific price within a certain time frame. Warrants are often included in a new debt issue to entice investors by a higher return potential. The main difference between warrants and call options is that warrants are issued and guaranteed by the company, whereas options are exchange instruments and are not issued by the company. Also, the lifetime of a warrant is often measured in years, while the lifetime of a typical option is measured in months. Disclose the title of issue of securities called for by warrants and rights outstanding, the aggregate amount of securities called for by warrants and rights outstanding, the date from which the warrants or rights are exercisable, and the price at which the warrant or right is exercisable. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 718 -SubTopic 10 -Section 50 -Paragraph 1 -Subparagraph (a) -URI http://asc.fasb.org/extlink&oid=120381028&loc=d3e5047-113901 Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 505 -SubTopic 50 -Section S99 -Paragraph 1 -URI http://asc.fasb.org/extlink&oid=6784392&loc=d3e188667-122775 + Details
Name: | us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Details
Name: | us-gaap_AwardTypeAxis=us-gaap_RestrictedStockMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |